IL-6 B and Κ Foxj1-Mediated Antagonism of NF- Restraint of B
Total Page:16
File Type:pdf, Size:1020Kb
Restraint of B Cell Activation by Foxj1-Mediated Antagonism of NF- κB and IL-6 This information is current as Ling Lin, Steven L. Brody and Stanford L. Peng of September 27, 2021. J Immunol 2005; 175:951-958; ; doi: 10.4049/jimmunol.175.2.951 http://www.jimmunol.org/content/175/2/951 Downloaded from References This article cites 32 articles, 14 of which you can access for free at: http://www.jimmunol.org/content/175/2/951.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 27, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2005 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Restraint of B Cell Activation by Foxj1-Mediated Antagonism of NF-B and IL-61 Ling Lin,* Steven L. Brody,† and Stanford L. Peng2*‡ The forkhead transcription factor Foxj1 inhibits spontaneous autoimmunity, in part by antagonizing NF-B activation in T cells. We demonstrate here that Foxj1 also inhibits humoral immune responses intrinsically in B cells; Foxj1 deficiency in B cells results in spontaneous and accentuated germinal center formation, associated with the development of pathogenic autoantibodies and accentuated responses to immunizations—all reflecting excessive activity of NF-B and its target gene IL-6, and correlating with a requirement for Foxj1 to regulate the inhibitory NF-B component IB. Thus, Foxj1 restrains B cell activation and the maturation of humoral responses, demonstrating a critical role for at least this forkhead transcription factor in the regulation of B lymphocyte homeostasis. The Journal of Immunology, 2005, 175: 951–958. Downloaded from ystemic autoimmune syndromes like lupus reflect patho- date the B cell-intrinsic function(s) of Foxj1, particularly its rela- genic, hyperactive T and B cell responses that culminate in tionship to Ag-specific Ab responses. We find that Foxj1 modu- S the production of pathogenic autoantibodies, such as anti- lates germinal center B cell formation in vivo via its ability to dsDNA (1). Recent studies suggest that deficient functions in fork- inhibit the NF-B-regulated cytokine IL-6 (7, 8). Foxj1 appears to head transcription factors, such as Foxj1 and Foxo3a, predispose to prevent inappropriate B cell responses at least in part by antago- such diseases, because their activities are significantly diminished nizing NF-B target genes like IL-6, which would otherwise prop- http://www.jimmunol.org/ in lupus lymphocytes and their deficiency results in spontaneous, agate pathogenic autoimmune responses through dysregulated B multisystem autoimmune syndromes characterized by autoreac- cell hyperactivation. tive, hyperactivated T cells (2, 3). Presumably, such hyperacti- vated T cells can promote pathogenic autoantibody production by Materials and Methods overexpressing costimulatory molecules and/or effector cytokines, Mice resulting in excessive autoreactive B cell activation. However, a 129, BALB/c, C57BL/6, C57BL/6-IgH , C57BL/6-CD45.1, BXSB, F1 both Foxj1 and Foxo3a are also expressed in B cells (2), and a (NZW ϫ NZB), MRL/ϩ, MRL/lpr, and athymic C57BL/6-nu/nu mice potential immunoregulatory role for the forkhead genes in B cells (The Jackson Laboratory), Rag-2Ϫ/Ϫ (Taconic Farms), and C57BL/6 Foxj1 Ϫ/Ϫ mice (9) were maintained under specific pathogen-free conditions at remains as yet undefined. by guest on September 27, 2021 Pathogenic autoantibody responses require somatic hypermuta- the Washington University School of Medicine. As judged by microsatel- lite markers, mice mutant for Foxj1, which is located on chromosome 11 tion and class switching of natural autoantibodies, such as in the at 78.0 cM, were homozygotic for C57BL/6 loci, including marker context of T-dependent germinal centers, to develop high-affinity, D11Mit333 (66.0 cM; 11qter is ϳ80.0 cM), indicating a Ͻ15 cM residual pathogenic activities, e.g., the production of anti-dsDNA from 129 contribution on chromosome 11. Foxj1 ϩ/ϩ and Ϫ/Ϫ fetal liver chi- 3 germline-encoded anti-ssDNA specificities (1, 4). Most circulating meras (FLCs) were generated in irradiated Rag-2-deficient hosts as pre- viously described (2). For B cell-only chimeras (BOC), fetal livers from natural autoantibodies are produced by natural Ab-secreting B Foxj1 ϩ/ϩ vs Ϫ/Ϫ (CD45.2ϩIgHb) embryos were adoptively transferred cells, such as B1 cells, or by plasma cells that have not undergone into irradiated C57BL/6-nu/nu hosts, and reconstitution of the peripheral B either affinity maturation or class switch recombination (5, 6). As cell lineage was allowed for 8–12 wk. Then, splenic B cell populations a result, the entry of an autoreactive B cell, when activated, into a were purified by negative selection against CD43 (Miltenyi Biotec), and adoptively transferred into C57BL/6-IgHa (for serological studies) or germinal center reaction, therefore, may contribute to and/or un- ϩ C56BL/6-CD45.1 (for flow cytometric studies) animals (one spleen derlie systemic autoimmune diseases like lupus (4, 6). equivalent, ϳ30–40 million B cells, per recipient), and animals were stud- To investigate the role of Foxj1 in B cells, we initiated a series ied 1–2 wk thereafter, as indicated in the text. All experiments were per- of experiments, including adoptive transfers, to isolate and eluci- formed in compliance with the relevant laws and institutional guidelines, as overseen by the Animal Studies Committee of the Washington University School of Medicine. * Division of Rheumatology and †Division of Pulmonary and Critical Care Medicine, In vivo studies Department of Internal Medicine and ‡Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110 Immunizations with 4-hydroxy-3-nitrophenylacetyl (NP)-chicken ␥ glob- ulin and NP-Ficoll were performed with 50 g of Ag in PBS (without Received for publication March 10, 2005. Accepted for publication May 13, 2005. adjuvant) administered i.p. as previously described (4). Where indicated, The costs of publication of this article were defrayed in part by the payment of page animals were treated with neutralizing anti-IL-6 (MP5-20F3; BD Pharm- charges. This article must therefore be hereby marked advertisement in accordance ingen) or control rat IgG Ab, 5 mg i.p. three times per week (10); or with with 18 U.S.C. Section 1734 solely to indicate this fact. RELA/p65 antisense (5Ј-GAAACAGATCGTCCATGGT) or mismatch 1 This work was supported in part by the Rheumatic Diseases, Siteman Cancer, Di- (5Ј-GGAACAGTTCGTCTATGGC) oligonucleotides, 800 g i.v. daily abetes Research and Training, and the Digestive Diseases Research Core (DK52574) (11). ELISA-based serological assessments, including determination of anti- Centers of the Washington University School of Medicine, as well as grants from the ssDNA using sheared salmon sperm DNA, anti-dsDNA using Crithidia National Institutes of Health (AI057471 and AI061478 to S.L.P.), Arthritis Founda- luciliae immunofluorescence, IgK rheumatoid factor (RF) activity using tion, and the Lupus Research Institute. S.L.P. is supported in part by an Arthritis Investigator Award from the Arthritis Foundation. 2 Address correspondence and reprint requests to Dr. Stanford L. Peng, Washington 3 Abbreviations used in this paper: FLC, fetal liver chimera; BOC, B cell-only chi- University School of Medicine, Campus Box 8045, Clinical Sciences Research Building mera; NP, 4-hydroxy-3-nitrophenylacetyl; PNA, peanut agglutinin; RF, rheumatoid 6617, 660 South Euclid Avenue, St. Louis, MO 63110. E-mail address: [email protected] factor. Copyright © 2005 by The American Association of Immunologists, Inc. 0022-1767/05/$02.00 952 ROLE OF Foxj1 IN B CELLS Table I. B cell characteristics of Foxj1 BOCsa B Cells (B220ϩ) NP-Binding GC-Like (PNAϩB220ϩ) Splenocytes Percentage of Chimeric Percentage of Chimeric Percentage of Chimeric Donor n (ϫ10Ϫ6) splenocytes (%) splenocytes (%) B cells (%) WT 5 67.0 Ϯ 2.5 62.2 Ϯ 1.5 2.2 Ϯ 0.16 2.2 Ϯ 0.32 2.6 Ϯ 0.38 3.9 Ϯ 1.1 2.7 Ϯ 0.3 Ϯ 0.13 5.6 Ϯ 0.32b 20.6 Ϯ 2.4b 52 Ϯ 4.3b 2.8 ءKO 5 68.8 Ϯ 3.8 64.6 Ϯ 4.2 9.9 Ϯ 0.76 a BOCs were generated first by chimerization of nu/nu animals by Foxj1 ϩ/ϩ or Ϫ/Ϫ fetal livers (CD45.2), the B cells of which were then adoptively transferred into wild-type C57BL/6-CD45.1 animals. Shown are flow cytometric data (means Ϯ SD) of representative spleens from such BOCs, quantifying the subpopulations indicated, after immunization with NP-Ficoll. Chimeric percentages indicate the percentage of CD45.2-staining cells of the subpopulations indicated. b Significant differences between wild-type (W/T) and knockout (K/O) donor cohorts ( p Ͻ 0.001). Ig IgGs, and anti-hapten responses using NP-BSA and TNP-BSA, were Table I . The PCR products were cloned into pCR2.1-TOPO (Invitrogen performed as described (4, 12). Germinal centers were identified by stain- Life Technologies), and their sequence was determined by routine ing frozen spleen sections with peanut agglutinin (PNA)-FITC, as previ- sequencing. ously described (4). Results In vitro B cell studies Spontaneous high-affinity autoantibodies in Foxj1 deficiency B cell purification and stimulation was performed similarly to a previous Downloaded from study (13).